Theralase® Launches Seventh US-Based Clinical Study Site and Treats First Patient in the US,

(“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of …, (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of …, Read More

Scroll to Top